HealthStream filings document the regulatory record for a Tennessee healthcare technology company listed on Nasdaq under HSTM. Its 8-K filings report quarterly and annual operating results, Regulation FD disclosures, dividend declarations, share repurchase programs, acquisitions and amendments to its revolving credit agreement.
The company’s proxy materials cover board matters, executive compensation, equity awards and shareholder voting items under its governance framework and incentive plans. Material-event filings also document executive appointments and related compensatory arrangements, while exhibits to current reports provide formal press releases and agreement summaries tied to HealthStream’s capital allocation, financing and workforce-technology operations.
HSTM filed a Form 144 notice reporting proposed sales of Common Stock through J.P. Morgan Securities LLC. The filing lists a proposed quantity of 3,000 shares associated with the broker and records two RSU awards dated 02/26/2025 (1,945 shares) and 03/26/2025 (1,055 shares). The filing shows a date of 05/20/2026.
HealthStream’s Executive Vice President Kevin P. O’Hara reported an open-market sale of 3,000 shares of the company’s common stock. The shares were sold at a weighted average price of $24.0765 per share, in multiple trades executed between $24.01 and $24.10.
After this transaction, O’Hara directly holds 20,982 shares of HealthStream common stock. The filing notes that detailed trade-by-trade pricing and share information is available on request for regulators, the company, or its shareholders.
HealthStream Inc executive Michael Manning Collier reported a new stock option award. He received 18,781 employee stock options to buy HealthStream common stock at an exercise price of $23.96 per share, expiring on May 8, 2036. These options vest over four years, with 15% vesting on May 8, 2027, 20% on each of May 8, 2028, May 8, 2029, and May 8, 2030, and the remaining 25% on May 8, 2031, contingent on continued service. Following this filing, he directly holds 60,293 shares of HealthStream common stock.
HEALTHSTREAM INC CEO and Chairman Robert A. Frist Jr. reported an equity compensation grant and updated indirect and direct holdings in HealthStream common stock. The filing shows a grant of employee stock options covering 18,781 shares of common stock at an exercise price of $23.96 per share.
The options vest over four years, with 15% on May 8, 2027, 20% on each of May 8, 2028, 2029, and 2030, and the remaining 25% on May 8, 2031, contingent on continued service. After this grant, Frist holds 4,051,106 shares directly, plus several indirect positions through various family and children’s trusts, including 995,000 shares held by the Bobby and Melissa Frist Children’s 2012 GST-Exempt Trust.
HealthStream, Inc. has promoted Michael M. Collier to Chief Operating Officer and Executive Vice President from his prior corporate strategy and operations role. He will oversee enterprise operations, including customer experience, corporate development, M&A, implementations, legal, HR, partnerships, business enablement, and other key functions.
Collier will also act as executive sponsor for the company’s AI transformation. In connection with his promotion, he received stock options for 18,781 shares at an exercise price of $23.96 per share under the 2022 Omnibus Incentive Plan, vesting over five years, and an increased base salary with eligibility for executive-level bonuses and time-based RSU awards.
The Compensation Committee also granted the CEO, Robert A. Frist, Jr., stock options for 18,781 shares at the same $23.96 exercise price, with identical five-year time-based vesting tied to continued service.
HealthStream, Inc. reported solid growth for the quarter ended March 31, 2026. Revenues rose to $81.2 million, up 11% from $73.5 million a year earlier, driven mainly by subscription services of $78.4 million and modest growth in professional services.
Operating income increased to $7.5 million from $4.4 million, while net income improved to $5.9 million, or $0.20 diluted EPS, compared with $4.3 million, or $0.14 diluted EPS, in the prior-year quarter. Adjusted EBITDA reached $20.1 million, up from $16.2 million.
The company ended the quarter with $48.7 million in cash and cash equivalents and $17.8 million in marketable securities, and had no outstanding borrowings under its $50 million revolving credit facility. It returned capital through $7.7 million of share repurchases and a quarterly dividend of $0.035 per share.
HealthStream, Inc. reported strong growth for the first quarter of 2026 and reaffirmed its full-year 2026 outlook. Revenue rose to $81.2 million, up 10.5% from $73.5 million a year earlier, driven by higher subscription and professional services revenues, including contributions from the 2025 Virsys12 and MissionCare Collective acquisitions.
Operating income increased to $7.5 million, up 71.6%, while net income grew to $5.9 million and diluted EPS reached $0.20, compared with $0.14 in the prior-year quarter. Adjusted EBITDA climbed 24.1% to $20.1 million. The company ended March 31, 2026 with $66.5 million in cash, cash equivalents, and marketable securities and no debt.
HealthStream returned capital through share repurchases and dividends, buying back 342,345 shares for $7.5 million at an average price of $21.91 during the quarter and declaring a quarterly dividend of $0.035 per share, payable May 29, 2026. The board also authorized a new $10.0 million repurchase program and the company reaffirmed 2026 guidance for revenue of $323–$330 million, net income of $20.4–$22.8 million, adjusted EBITDA of $73–$77 million, and capital expenditures of $31–$34 million. Additionally, HealthStream promoted Michael M. Collier to Chief Operating Officer & Executive Vice President.
HealthStream, Inc. calls a fully virtual 2026 annual meeting for May 28, 2026 at 2:00 p.m. Central, where holders of 29,421,632 common shares as of March 30, 2026 may vote online.
Shareholders will elect three Class II directors, ratify Ernst & Young LLP as auditor for 2026, and cast an advisory vote on executive pay. The proxy details a classified nine‑member board, independent audit, compensation, and nominating committees, director and executive biographies, ESG and risk-oversight practices, and a clawback, insider trading, and anti‑hedging framework. It also outlines director cash retainers and RSU grants and explains how performance-based RSUs and special option/RSU awards link named executive officer compensation to adjusted EBITDA and other financial goals.
HealthStream Executive Vice President Trisha L. Coady exercised restricted share units that vested into 5,672 shares of common stock on March 30, 2026. These awards vested at no exercise price as part of multi-year RSU compensation grants.
To cover tax obligations on the vesting, 1,382 shares of common stock were withheld at $21.25 per share. After these routine compensation and tax-withholding transactions, Coady directly holds 39,495 shares of HealthStream common stock. The underlying RSUs follow four-year vesting schedules tied to continued service and, for some awards, achievement of performance criteria set by the Compensation Committee.